arctic semaglutide Novo Nordisk's shortage officially concludes in the US, spelling major threat for weight loss drug compounders Ozempic® | GoodGirlRx

News provided by Ro Apr 09, 2026, 07:15 ET Foundayo gives patients a new once daily pill option and expands Ro's comprehensive weight loss formulary NEW YORK, April 9, 2026 /PRNewswire/ -- Ro, the leading direct-to-patient healthcare company, today announced eligible patients can now access Foundayo (orforglipron) Eli Lilly Company's newest oral GLP-1 innovation on the Ro platform, adding to Ro's already comprehensive formulary of FDA-approved GLP-1s

When you aim to achieve the same periodic average as the 7-day dosing, with the shorter period, each dose needs to be around 55%-60% of the normal 7-day dose

Leo Lapuerta today to learn more about semaglutide injections and what they can do for you

Seventy percent of covered workers in firms that offer health benefits work in firms that offer one or more PPOs

Tirzepatide seems to be moving beyond a metabolic drug into a true disease-modifying option in MASLD/MASH

30-A, Jalan 17/155C, Bandar Bukit Jalil Kuala Lumpur, Wilayah Persekutuan Kuala Lumpur 57000 Resources Partner With Us Policies SSL SECURE 256-bit Encryption VERIFIED Malaysian Business Educational Purposes Only: All content is for educational purposes only and does not constitute medical advice